This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kagiyama, S. Articles by Galli, S. M. Search for Related Content PubMed PubMed Citation Articles by Kagiyama, S. Articles by Galli, S. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Other hypertension

(Hypertension. 2001;37:371.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Antisense Inhibition of Brain Renin-Angiotensin System Decreased Blood Pressure in Chronic 2-Kidney, 1 Clip Hypertensive Rats

Shuntaro Kagiyama; Adrian Varela; M. Ian Phillips; Sara M. Galli

From the Department of Physiology, School of Medicine, University of Florida, Gainesville.

Correspondence to Dr Sara M. Galli, Department of Physiology, School of Medicine, University of Florida, Box 100274, 1600 SW Archer Rd, Gainesville, FL 32610. E-mail smgalli{at}phys.med.ufl.edu

The systemic renin-angiotensin system (RAS) plays an important role in blood pressure (BP) regulation during the development of 2-kidney, 1 clip (2K1C) hypertension. Its contributions decrease with time after constriction of the renal artery. During the chronic phase, the peripheral RAS returns to normal, but the hypertension is sustained for months. We hypothesized that in this phase the brain RAS contributes to the maintenance of high BP. To test the hypothesis, we studied the role of brain RAS by decreasing the synthesis of angiotensinogen (AGT) and the angiotensin II (Ang II) type 1a receptor (AT₁R) with intracerebroventricular injections of antisense oligonucleotides (AS-ODNs). The response of systolic BP (SBP) to AS-ODNs to AGT mRNA was studied in 2K1C rats at 6 months after clipping, and the response to AS-ODNs to AT₁R mRNA was studied at 10 months after clipping. Intracerebroventricular injection of AS-ODN-AGT (200 µg/kg, n=5) significantly decreased SBP (-22±6 mm Hg, P<0.05) compared with the sense ODN (n=5) and saline (n=3) groups. Intracerebroventricular injection of AS-ODN-AGT reduced the elevated hypothalamic Ang II level. The hypothalamic Ang II content in sense ODN and saline groups was significantly (P<0.05) higher than in the nonclipped group. Compared with inverted ODN, intracerebroventricular injection of AS-ODN-AT₁R (250 µg/kg, n=6) significantly decreased SBP (-26±8 mm Hg, P<0.05) for 3 days after injection. This was a brain effect because intravenous AS-ODN-AT₁R at a dose of 250 to 500 µg/kg did not affect SBP. These results suggest that the brain RAS plays an important role in maintaining the elevated SBP in chronic 2K1C hypertension.

Key Words: rats • renin-angiotensin system • brain • hypertension, 2K1C • antisense

This article has been cited by other articles:

				D. I. Diz Future Directions in Cardiovascular Pharmacology: Examples from the Renin-Angiotensin System Mol. Interv., October 1, 2008; 8(5): 222 - 225. [Abstract] [Full Text] [PDF]

				J. W. Weiss, M. D. Y. Liu, and J. Huang Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension Exp Physiol, January 1, 2007; 92(1): 21 - 26. [Abstract] [Full Text] [PDF]

				T.-M. Lee, M.-S. Lin, C.-H. Tsai, and N.-C. Chang Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2705 - H2713. [Abstract] [Full Text] [PDF]

				M. J. Sheriff, M. A. P. Fontes, S. Killinger, J. Horiuchi, and R. A. L. Dampney Blockade of AT1 receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R733 - R740. [Abstract] [Full Text] [PDF]

				D. I. Diz Approaches to Establishing Angiotensin II as a Neurotransmitter Revisited Hypertension, March 1, 2006; 47(3): 334 - 336. [Full Text] [PDF]

				G.-Q. Zhu, L. Gao, Y. Li, K. P. Patel, I. H. Zucker, and W. Wang AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1828 - H1835. [Abstract] [Full Text] [PDF]

				H. Wang, S. Gallinat, H.-w. Li, C. Sumners, M. K. Raizada, and M. J. Katovich Elevated blood pressure in normotensive rats produced by 'knockdown' of the angiotensin type 2 receptor Exp Physiol, May 1, 2004; 89(3): 313 - 322. [Abstract] [Full Text] [PDF]

				R. L. Davisson Physiological genomic analysis of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511. [Abstract] [Full Text] [PDF]

				S. Ito, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved Ventrolateral Medulla AT1 Receptors Support Blood Pressure in Hypertensive Rats Hypertension, October 1, 2002; 40(4): 552 - 559. [Abstract] [Full Text] [PDF]

				P. Sinnayah, T. E. Lindley, P. D. Staber, M. D. Cassell, B. L. Davidson, and R. L. Davisson Selective Gene Transfer to Key Cardiovascular Regions of the Brain: Comparison of Two Viral Vector Systems Hypertension, February 1, 2002; 39(2): 603 - 608. [Abstract] [Full Text] [PDF]

				S. M. Galli and M. I. Phillips Angiotensin II AT1A Receptor Antisense Lowers Blood Pressure in Acute 2-Kidney, 1-Clip Hypertension Hypertension, September 1, 2001; 38(3): 674 - 678. [Abstract] [Full Text] [PDF]